| ACD | Anemia of chronic disease |
| ALK | Anaplastic lymphoma kinase |
| AR | Adrenergic receptor |
| Bcr-Abl | Break point cluster-Abelson |
| Btk | Bruton’s tyrosine kinasel |
| CD | Crohn’s disease |
| CDK | Cyclin-dependent kinase |
| CHK | Checkpoint kinase |
| DCE | 1,2-Dichloroethane |
| DDQ | 2,3-Dicyano-5,6-dichlorobenzoquinone |
| DFT | Density functional theory |
| DMPK | Drug metabolism and pharmacokinetics |
| DMPU | 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone |
| DMSO | Dimethyl sulfoxide |
| EGFR | Epidermal growth factor receptor |
| ER | Endoplasmic reticulum |
| ERK | Extracellular signal-regulated kinase |
| EZH | Enhancer of zeste homologue |
| FBLD | Fragment-based lead discovery |
| FDA | Food and drug administration |
| FGFR | Fibroblast growth factor receptor |
| FRET | Forster resonance energy transfer |
| FLT3 | Fms-like tyrosine kinase 3 |
| FtsZ | Filamentous temperature-sensitive protein Z |
| GK | Glucokinase |
| GPR | G-protein coupled receptor |
| GR | Glucocorticoid receptor |
| GRAs | Glucagon receptor antagonists |
| GRK | G protein-coupled receptor kinase |
| GSK3β | Glycogen synthase kinase 3 betas |
| hCAs | Human carbonic anhydrases |
| HDACs | Histone deacetylases |
| hEGR | Human ether-a-go-go related gene |
| hFOB | Human fetal osteoblasts |
| HFIP | Hexafluoroisopropanol |
| HT | Hydroxytryptamine |
| HTS | High-throughput screening |
| HUVEC | Human umbilical vein endothelial cells |
| IDO | Indoleamine-pyrrole 2,3-dioxygenase |
| IKKβ | Inhibitor of nuclear factor kappa-B kinase betan |
| JAK | Janus kinase |
| LE | Excellent ligand |
| LPS | Lipopolysaccharide |
| LRRK | Leucine-rich repeat kinase |
| MA | Molecular sieves |
| MAC | Membrane attack complex |
| MBA | Methoxybenzamide |
| MCHR | Melanin-concentrating hormone receptor |
| MIC | Minimum inhibitory concentration |
| NMT | N-myristoyltransferase |
| NMR | Nuclear magnetic resonance |
| NOD | Nucleotide-binding oligomerization domain-containing protein |
| NSCLC | Non-small cell lung cancer |
| OGTT | Oral glucose tolerance test |
| OPG | Osteoprotegerin |
| PAD | Protein arginine deiminase |
| PD | Pharmacodynamic |
| PDGFRβ | Platelet-derived growth factor receptor betan |
| PDK | Phosphoinositide-dependent kinase |
| PEC | Posterior eye cup |
| PI3Kδ | Phosphoinositide 3-kinase deltae |
| PIFA | [Bis-(trifluoroacetoxy)iodo]benzene |
| PK | Pharmacokinetic |
| PKC | Protein kinase C |
| PLK4 | Polo-like kinase 4 |
| RET | Rearranged during transfection |
| RIP | Receptor-interacting protein |
| ROCK | Rho-associated coiled-coil kinase |
| SAHA | Suberoylanilide hydroxamic acid |
| SAR | Structure-activity relationship |
| SCW | Streptococcal cell wall |
| SEDRs | Selective estrogen receptor degraders |
| SGRMs | Selective glucocorticoid receptor modulators |
| SNAr | Nucleophilic aromatic substitution |
| TA | Transactivation |
| TAT | Tyrosine aminotransferase |
| TGI | Tumor growth inhibition |
| TNFα | Tumor necrosis factor-alphas |
| TTK | Tyrosine threonine kinase |
| TR | Transrepression |
| TRPA | Transient receptor potential ankyrin-repeat |
| UC | Ulcerative colitis |
| ULK | Unc-51-like kinase |
| USP | Ubiquitin specific protease |
| VEGFR | Vascular endothelial growth factor receptor |